Use of artificial intelligence-based digital pathology to predictoutcomes for immune checkpoint inhibitor therapy in advancedgastro-esophageal cancer.
价格：15.00微豆大小：3.03 MB
Tumor Microbiome Differences inEarly-onset versus Average-onsetPancreatic Adenocarcinoma
价格：15.00微豆大小：3.12 MB
Safety, tolerability and efficacy of 21Pb-DOTAMTATE asa targeted alpha therapy for subjects with unresectableor metastatic somatostatin receptor-expressinggastroenteropancreatic neuroendocrine
价格：15.00微豆大小：3.09 MB
Refining Treatment in AdvancedHepatobiliary Cancers
价格：15.00微豆大小：5.89 MB
Randomized phase lllll trial of gemcitabine plusnab-paclitaxel versus. concurrentchemoradiotherapy with S-1 as neoadjuvanttreatment for borderline resectable pancreaticcancerGABARNANCE study
价格：15.00微豆大小：3.45 MB
Ramucirumab plus paclitaxel as switch maintenanceversus continuation of oxaliplatin-based chemotherapyin patients with advanced HER2-negative gastric orgastroesophagealjunction cancerthe ARMAN
价格：15.00微豆大小：3.56 MB
Phasel study of C-CAR031, aGPc3-specificTGFBRllDN armored autologous CAR-T, inpatients with advanced hepatocellularcarcinoma(Hcc)
价格：15.00微豆大小：12.08 MB
Phase ll study of sitravatinib in combination withtislelizumab in patients with advanced biliary tractcancer who have failed to at least 1 prior systemictreatment
Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer systematic review and indirect comparison of randomized trials
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
价格：20.00微豆大小：453.18 KB
Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET) a phase II study
价格：20.00微豆大小：1.37 MB
A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)
价格：20.00微豆大小：8.3 MB
A phase 12a trial of yttrium-90 radioembolization in combination with durvalumab for locally advanced unresectable hepatocellular carcinoma
距离恢复原价还有：
关注公众号
安卓客户端
